STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer.
Mohanty SK, Yagiz K, Pradhan D, Luthringer DJ, Amin MB, Alkan S, Cinar B. STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer. Oncotarget. 2017 Oct 17; 8(49):85997-86010.